FDA Issues Draft Guidance on Conducting Multiregional Clinical Trials in Oncology

Estimated reading time: 1 minutes

• About The Author

The FDA issued a draft guidance that, when finalized, will provide sponsors with recommendations on multiregional clinical trials (MRCT) conducted to support applications for drugs intended to treat cancer.

About The Author

See author's posts

Trending

Android malware steals payment card data using previously unseen technique